Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk

Clinical trial NCT00682292 · COMPLETED

Trial details

NCT number: NCT00682292
Sponsor: University Hospital, Lille
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Renal Transplantation

Start date: 2001-05-01
Primary completion: 2006-11-01
Enrollment: 227

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.